临床精神医学杂志
臨床精神醫學雜誌
림상정신의학잡지
JOURNAL OF CLINICAL PSYCHOLOGICAL MEDICINE
2015年
4期
238-240
,共3页
重复经颅磁刺激%舍曲林%难治性强迫症
重複經顱磁刺激%捨麯林%難治性彊迫癥
중복경로자자격%사곡림%난치성강박증
repetitive transcranial magnetic stimulation%sertraline%obsessive compulsive disorder
目的:比较舍曲林单用或合并重复经颅磁刺激(rTMS)治疗难治性强迫症患者的临床疗效。方法:将60例强迫症患者随机分成研究组(舍曲林+ rTMS)和对照组(舍曲林+ rTMS 伪刺激),疗程8周。治疗前及治疗2、4、6、8周后进行耶鲁布朗强迫症状量表(Y-BOCS)评定,治疗2、4、6、8周后进行治疗中出现的症状量表(TESS)评定,治疗前后进行世界卫生组织生活质量测定量表( WHOQOL-100)评定。结果:治疗4周末起两组 Y-BOCS 评分较治疗前显著降低(P 均﹤0.01);且研究组评分较对照组下降更显著(t =3.536、2.367、2.519;P ﹤0.05或 P ﹤0.01)。治疗8周末研究组总有效率(92.9%)显著高于对照组(67.8%)(P ﹤0.05)。在治疗第8周末,研究组 WHOQOL-100中社会关系、独立性、心理及生理评分显著高于对照组(P ﹤0.05或 P ﹤0.01);治疗第4周末研究组 TESS 评分显著高于对照组(P ﹤0.01)。结论:舍曲林联合 rTMS 对难治性强迫症患者的疗效及生活质量影响均优于单用舍曲林。
目的:比較捨麯林單用或閤併重複經顱磁刺激(rTMS)治療難治性彊迫癥患者的臨床療效。方法:將60例彊迫癥患者隨機分成研究組(捨麯林+ rTMS)和對照組(捨麯林+ rTMS 偽刺激),療程8週。治療前及治療2、4、6、8週後進行耶魯佈朗彊迫癥狀量錶(Y-BOCS)評定,治療2、4、6、8週後進行治療中齣現的癥狀量錶(TESS)評定,治療前後進行世界衛生組織生活質量測定量錶( WHOQOL-100)評定。結果:治療4週末起兩組 Y-BOCS 評分較治療前顯著降低(P 均﹤0.01);且研究組評分較對照組下降更顯著(t =3.536、2.367、2.519;P ﹤0.05或 P ﹤0.01)。治療8週末研究組總有效率(92.9%)顯著高于對照組(67.8%)(P ﹤0.05)。在治療第8週末,研究組 WHOQOL-100中社會關繫、獨立性、心理及生理評分顯著高于對照組(P ﹤0.05或 P ﹤0.01);治療第4週末研究組 TESS 評分顯著高于對照組(P ﹤0.01)。結論:捨麯林聯閤 rTMS 對難治性彊迫癥患者的療效及生活質量影響均優于單用捨麯林。
목적:비교사곡림단용혹합병중복경로자자격(rTMS)치료난치성강박증환자적림상료효。방법:장60례강박증환자수궤분성연구조(사곡림+ rTMS)화대조조(사곡림+ rTMS 위자격),료정8주。치료전급치료2、4、6、8주후진행야로포랑강박증상량표(Y-BOCS)평정,치료2、4、6、8주후진행치료중출현적증상량표(TESS)평정,치료전후진행세계위생조직생활질량측정량표( WHOQOL-100)평정。결과:치료4주말기량조 Y-BOCS 평분교치료전현저강저(P 균﹤0.01);차연구조평분교대조조하강경현저(t =3.536、2.367、2.519;P ﹤0.05혹 P ﹤0.01)。치료8주말연구조총유효솔(92.9%)현저고우대조조(67.8%)(P ﹤0.05)。재치료제8주말,연구조 WHOQOL-100중사회관계、독립성、심리급생리평분현저고우대조조(P ﹤0.05혹 P ﹤0.01);치료제4주말연구조 TESS 평분현저고우대조조(P ﹤0.01)。결론:사곡림연합 rTMS 대난치성강박증환자적료효급생활질량영향균우우단용사곡림。
Objective:To compare the clinical curative effect of sertraline alone or combined repetitive transcranial magnetic stimulation(rTMS)in patients with refractory obsessive- compulsive disorder(rOCD). Method:Sixty rOCD patients were randomly divided into study group(treated with sertraline + rTMS)and the control group(treated with sertraline + false stimulation of rTMS),and treated for 8 weeks. The patients were assessed by Yale brown obsessional-compulsive scale( Y-BOCS)before treatment and 2,4,6,8 weeks after treatment,treatment emergent symptoms scale(TESS)at 2,4,6,8 weeks after treatment,and the World Health Organization quality of life scale(WHOQOL-100)before and after treatment. Results:Since the end of the 4th week after treatment,the Y-BOCS scores of the two groups were significantly reduced than before treatment (all P ﹤ 0. 01);and those in the study group were more obvious than the control group( t = 3. 536,2. 367, 2. 519;P ﹤ 0. 05 or P ﹤ 0. 05). The end of the 8th week after treatment,the total effective rate of the study group (92. 9% )was significant higher than the control group(67. 8% )(P ﹤ 0. 05);and the scores of social rela-tions,independence,psychological and physiological of WHOQOL-100 in the study group were significant high-er than the control group(P ﹤ 0. 05 or P ﹤ 0. 01). The score of TESS in the study group was significantly higher than the control group just in the end of 4th week(P ﹤ 0. 01). Conclusion:For rOCD patients,sertraline combined rTMS has better curative effect and influence on the quality of life than sertraline alone.